Olanzapine-Samidorphan for Schizophrenia: A Systematic Review and Meta-Analysis.

Published in: Indian journal of psychological medicine (2023)

The combination OLZSAM showed comparable efficacy to olanzapine alone in schizophrenia patients, with relatively less incidence of weight gain and adverse events; however, the drug discontinuation due to adverse events was more in the OLZSAM group.

Keyphrases

weight gain
bipolar disorder
body mass index
birth weight
risk factors
chemotherapy induced
weight loss
emergency department
adverse drug
physical activity
gestational age
drug induced